News of the WeekU.S. BIOMEDICAL POLICY

Acting FDA Head Drops NCI Post

+ See all authors and affiliations

Science  07 Oct 2005:
Vol. 310, Issue 5745, pp. 29
DOI: 10.1126/science.310.5745.29

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Trying to calm an uproar after he took a second job, the chief of the U.S. National Cancer Institute (NCI) declared last week that he would take a leave of absence while he serves as acting commissioner of the Food and Drug Administration (FDA).

Related Content